BRIEF-Sunshine Biopharma Receives Canadian Regulatory Approval For Enalapril
Sunshine Biopharma Inc SBFM.O:
SUNSHINE BIOPHARMA: RECEIVES CANADIAN REGULATORY APPROVAL FOR ENALAPRIL
SUNSHINE BIOPHARMA: ENALAPRIL EXPECTED TO BEGIN SHIPPING TO CANADIAN PHARMACIES BY YEAR-END 2026
Source text: [ID:]
Further company coverage: SBFM.O
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Trade now！
You may also like
Crypto prices
More
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now